Oak Street Health, Inc. (OSH) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED 2023
What happened to Oak Street Health, Inc. (OSH) stock?
Oak Street Health, Inc. (OSH) no longer trades on public markets. It was delisted in May 2023. The figures below are historical and are not a current quote.
Market cap $9.52B is the value of all shares combined. Beta 2.23: the stock has moved about 123% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Oak Street Health, Inc. (OSH). Oak Street Health, Inc. operates primary care centers focused on Medicare beneficiaries. The company aims to improve health outcomes and reduce costs by providing comprehensive, coordinated care. Market cap: $9.52B, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for OSH: OSH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OSH against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
OSH: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Oak Street Health, Inc. (OSH) Healthcare & Pipeline Overview
Oak Street Health, founded in 2012, operates primary care centers for Medicare beneficiaries, focusing on value-based care. With 129 centers across 19 states, the company aims to improve health outcomes and reduce costs through a patient-centered model. It faces competition in the evolving healthcare landscape.
What Is the Investment Thesis for OSH?
Oak Street Health presents a compelling, albeit high-risk, investment thesis centered on its value-based care model for Medicare beneficiaries. The company's growth is predicated on expanding its network of primary care centers and increasing patient enrollment. Key value drivers include improving patient health outcomes, reducing healthcare costs, and securing favorable contracts with Medicare plans. The company's negative P/E ratio of -17.61 and negative profit margin of -23.6% highlight current profitability challenges. Ongoing: The company's high beta of 2.23 indicates significant volatility relative to the market. Upcoming: Expansion into new geographic markets and strategic partnerships with healthcare providers could drive future growth. However, regulatory changes and competition from other healthcare providers pose potential risks.
Based on FMP financials and quantitative analysis
OSH Key Highlights
Operates 129 primary care centers across 19 states as of December 31, 2021, demonstrating a significant geographic footprint.
- Focuses exclusively on Medicare beneficiaries, targeting a large and growing demographic.
- Employs a value-based care model, aligning incentives with payers to improve health outcomes and reduce costs.
- Achieved a gross margin of 3.6%, indicating potential for improvement as the company scales.
- Trades with a beta of 2.23, reflecting higher volatility compared to the broader market.
Who Are OSH's Competitors?
OSH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BPMC Blueprint Medicines Corporation | $129.46 | +0.14% | $8.36B | — |
| CERE Cerevel Therapeutics Holdings, Inc. | $44.96 | +0.74% | $8.19B | — |
| CTLT Catalent, Inc. | $63.48 | 0.00% | $11.5B | — |
| IMGN ImmunoGen | $31.23 | +0.02% | $8.73B | — |
| KRTX Karuna Therapeutics | $329.83 | +0.03% | $12.6B | — |
| ENSG The Ensign Group, Inc. | $172.79 | +0.60% | $10.1B | 745-pillar |
| UHS Universal Health Services, Inc. | $172.72 | -1.74% | $10.5B | 935-pillar |
| DVA DaVita Inc. | $181.33 | -0.92% | $11.6B | 745-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OSH's Key Strengths?
Focus on value-based care.
- Specialization in Medicare beneficiaries.
- Integrated care model.
- Growing geographic footprint.
What Are OSH's Weaknesses?
Negative profitability.
- High beta indicating volatility.
- Reliance on Medicare payments.
- Limited brand recognition outside of existing markets.
What Could Drive OSH Stock Higher?
Expansion into new geographic markets, increasing patient enrollment and revenue.
- Strategic partnerships with Medicare plans, securing favorable contracts.
- Technology-enabled care coordination, improving patient outcomes and reducing costs.
- Potential acquisitions of smaller healthcare providers, expanding market share.
- Positive results from clinical trials or research studies, demonstrating the effectiveness of the Oak Street Health model.
What Are the Key Risks for OSH?
Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 7 reported quarters.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Insider selling — insiders were net sellers of roughly $1.3B recently.
- Regulatory changes in healthcare, impacting reimbursement rates and operational requirements.
- Competition from other healthcare providers, eroding market share.
- Changes in Medicare reimbursement policies, reducing revenue.
- Economic downturn affecting patient access to care, decreasing enrollment.
- Negative profitability, requiring continued investment and financing.
What Are the Growth Opportunities for OSH?
- Expansion into New Geographic Markets: Oak Street Health has the opportunity to expand its network of primary care centers into new geographic markets with large Medicare populations. By targeting underserved areas and establishing partnerships with local healthcare providers, the company can increase its patient base and revenue. The market for Medicare primary care is estimated to be worth billions of dollars, providing ample room for growth. Timeline: Ongoing expansion efforts with new centers planned for 2026 and beyond.
- Increased Patient Enrollment: Oak Street Health can drive growth by increasing patient enrollment at its existing centers. By enhancing its marketing efforts, improving patient engagement, and expanding its service offerings, the company can attract more Medicare beneficiaries to its centers. The company's focus on providing personalized care and addressing the social determinants of health can help it differentiate itself from competitors. Timeline: Continuous efforts to improve patient acquisition and retention.
- Strategic Partnerships with Medicare Plans: Oak Street Health can strengthen its position by forging strategic partnerships with Medicare plans. By collaborating with payers to develop innovative care models and share risk, the company can secure favorable contracts and increase its revenue. The shift towards value-based care is creating new opportunities for partnerships between providers and payers. Timeline: Ongoing negotiations with Medicare plans for new and expanded contracts.
- Technology-Enabled Care Coordination: Oak Street Health can leverage technology to enhance care coordination and improve patient outcomes. By investing in telehealth platforms, remote monitoring devices, and data analytics capabilities, the company can provide more efficient and effective care. The use of technology can also help the company reduce administrative costs and improve operational efficiency. Timeline: Continuous investment in technology infrastructure and digital health solutions.
- Expansion into Ancillary Services: Oak Street Health can expand its service offerings to include ancillary services such as pharmacy, dental, and vision care. By providing a more comprehensive range of services, the company can increase patient loyalty and generate additional revenue. The integration of ancillary services can also improve care coordination and address the holistic needs of patients. Timeline: Potential expansion into ancillary services within the next 3-5 years.
What Are OSH's Competitive Advantages?
- Focus on Medicare beneficiaries creates specialization.
- Value-based care model aligns incentives with payers.
- Integrated care teams and technology enhance care coordination.
- Geographic footprint provides a network effect.
What Does OSH Do?
Founded in 2012 and headquartered in Chicago, Illinois, Oak Street Health, Inc. is a healthcare company focused on delivering value-based primary care services to Medicare beneficiaries. The company operates through its subsidiaries, providing comprehensive healthcare services to patients across the United States. Oak Street Health's core business revolves around operating primary care centers specifically designed to cater to the unique needs of older adults. As of December 31, 2021, Oak Street Health operated 129 centers located in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. These centers offer a range of services, including preventive care, chronic disease management, and behavioral health support. The company's model emphasizes longer appointment times, integrated care teams, and technology-enabled care coordination to improve patient outcomes and reduce healthcare costs. Oak Street Health partners with Medicare plans to receive capitated payments, aligning incentives to focus on keeping patients healthy. The company's approach involves proactive outreach, personalized care plans, and community-based programs to address the social determinants of health. By focusing on preventive care and early intervention, Oak Street Health aims to reduce hospitalizations and emergency room visits, ultimately lowering the overall cost of care for Medicare beneficiaries.
What Products and Services Does OSH Offer?
- Operates primary care centers specifically for Medicare beneficiaries.
- Provides comprehensive healthcare services, including preventive care and chronic disease management.
- Focuses on value-based care, aiming to improve health outcomes and reduce costs.
- Offers longer appointment times and integrated care teams.
- Utilizes technology to enhance care coordination and patient engagement.
- Partners with Medicare plans to receive capitated payments.
- Addresses the social determinants of health through community-based programs.
How Does OSH Make Money?
- Generates revenue through capitated payments from Medicare plans.
- Receives a fixed payment per patient per month, regardless of the number of services used.
- Focuses on preventive care and early intervention to reduce hospitalizations and emergency room visits.
- Manages risk by improving patient health outcomes and controlling healthcare costs.
What Industry Does OSH Operate In?
Oak Street Health operates within the rapidly evolving healthcare industry, specifically in the market for primary care services for Medicare beneficiaries. The industry is characterized by a shift towards value-based care models, driven by the increasing need to control healthcare costs and improve patient outcomes. The competitive landscape includes traditional primary care providers, large healthcare systems, and other emerging value-based care companies. Oak Street Health differentiates itself through its focus on older adults, its integrated care model, and its use of technology to enhance care coordination. The aging population and the increasing prevalence of chronic diseases are driving demand for specialized primary care services, creating significant growth opportunities for companies like Oak Street Health.
Who Are OSH's Key Customers?
- Medicare beneficiaries
- Medicare plans
- Patients in underserved communities
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Company Profile
Oak Street Health, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Chicago, US. The company is led by CEO Michael T. Pykosz. OSH has traded publicly since 2020.
How Oak Street Health, Inc. Is Valued
Oak Street Health, Inc. carries a market capitalization of $9.52B, placing it in the mid-cap category.
Key Financial Metrics
Return on equity for Oak Street Health, Inc. stands at 464.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -24.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -4.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -5.7%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Oak Street Health, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.89 places it in the grey zone, a middle ground that warrants monitoring.
Earnings Track Record
Oak Street Health, Inc. has missed Wall Street's EPS estimate in 5 of its last 7 reported quarters — a mixed record worth weighing. Reported results have landed about 13.3% below estimates on average.
Insider Activity
The most recent 12 insider filings for Oak Street Health, Inc. break down as 10 sales and 2 purchases. On net that is roughly 33.2M shares disposed (about $1.3B), a signal worth weighing alongside the fundamentals.
OSH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Focus on value-based care.
- Specialization in Medicare beneficiaries.
- Integrated care model.
- Growing geographic footprint.
Bear Case
- Negative profitability.
- High beta indicating volatility.
- Reliance on Medicare payments.
- Limited brand recognition outside of existing markets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
OSH Latest News
-
Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health
benzinga · Apr 21, 2023
-
Oak Street Health Entered Default Waiver And First Amendment To Loan And Security Agreement With Hercules Capital, Silicon Valley Bank; Amendment Provides Co May Maintain Cash In Certain Accounts Outside Of SVB And Affiliates In Amount Not To Exceed $65B
benzinga · Apr 10, 2023
-
Top 5 Health Care Stocks That May Collapse
benzinga · Mar 31, 2023
-
Senator Elizabeth Warren Has Urged The FTC To Review CVS' $9.5B Acquisition Of Oak Street Health; Other Merger Deals In The Sector
benzinga · Mar 22, 2023
Latest News
Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health
Oak Street Health Entered Default Waiver And First Amendment To Loan And Security Agreement With Hercules Capital, Silicon Valley Bank; Amendment Provides Co May Maintain Cash In Certain Accounts Outside Of SVB And Affiliates In Amount Not To Exceed $65B
Top 5 Health Care Stocks That May Collapse
Senator Elizabeth Warren Has Urged The FTC To Review CVS' $9.5B Acquisition Of Oak Street Health; Other Merger Deals In The Sector
Leadership: Michael T. Pykosz
CEO
Michael T. Pykosz is the Chief Executive Officer of Oak Street Health, leading a team of 6,000 employees. His career reflects a deep commitment to improving healthcare delivery and outcomes. Prior to Oak Street Health, Pykosz held leadership positions in various healthcare organizations. He has a strong background in healthcare operations, finance, and strategy. Pykosz's expertise lies in developing and implementing innovative care models that improve patient experiences and reduce costs. He is a frequent speaker at industry conferences and a thought leader on value-based care.
Track Record: Under Michael T. Pykosz's leadership, Oak Street Health has expanded its network of primary care centers to 129 locations across 19 states. He has overseen the company's growth from a small startup to a publicly traded company with a market capitalization of $9.52B. Pykosz has successfully navigated the complex regulatory landscape of the healthcare industry and has forged strategic partnerships with Medicare plans. He has also led the company's efforts to develop and implement technology-enabled care coordination solutions.
OSH Healthcare Stock FAQ
What happened to Oak Street Health, Inc. (OSH) stock?
Oak Street Health, Inc. (OSH) no longer trades on public markets. It was delisted in May 2023. The figures below are historical and are not a current quote.
Can I still buy OSH shares?
No. OSH stopped trading on public markets in May 2023, so the shares are not available through a broker. Anything you see quoted for OSH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OSH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Oak Street Health, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Oak Street Health, Inc. do?
Oak Street Health, Inc. operates primary care centers catering specifically to Medicare beneficiaries. The company's core focus is delivering value-based care, which emphasizes improving patient health outcomes while simultaneously reducing healthcare costs.
What do analysts say about OSH stock?
Analyst consensus on Oak Street Health, Inc. stock is mixed, reflecting the company's high-growth potential and current profitability challenges. Key valuation metrics, such as the negative P/E ratio, highlight the company's ongoing investments in expansion and technology.
What are the main risks for OSH?
Oak Street Health, Inc. faces several key risks, including regulatory changes in the healthcare industry, competition from other healthcare providers, and changes in Medicare reimbursement policies.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is based on information available as of 2021-12-31. More recent data may impact the analysis.